Zsofia Sztupinszki Selected Research

Zsofia Sztupinszki Research Topics

Disease

19	Neoplasms (Cancer) 04/2024 - 01/2020
8	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2020
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2021
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 11/2023 - 02/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 02/2023
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2021
2	Melanoma (Melanoma, Malignant) 10/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 06/2021 - 01/2020
1	Stomach Neoplasms (Stomach Cancer) 04/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2021
1	Adenocarcinoma of Lung 06/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Cicatrix (Scar) 01/2021

Drug/Important Bio-Agent (IBA)

9	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 01/2020
6	PlatinumIBA 04/2024 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2022
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2023 - 01/2021
3	irofulvenIBA 11/2023 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 01/2021
2	olaparibIBA 04/2024 - 06/2022
2	AntigensIBA 01/2024 - 01/2020
2	NucleotidesIBA 10/2023 - 01/2023
2	Pattern Recognition ReceptorsIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 01/2021
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Carrier Proteins (Binding Protein)IBA 04/2024
1	talazoparibIBA 04/2024
1	DNA HelicasesIBA 04/2024
1	AntibodiesIBA 01/2024
1	Forssman AntigenIBA 01/2024
1	GlycolipidsIBA 01/2024
1	Blood Group Antigens (Blood Groups)IBA 01/2024
1	CarbohydratesIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	CholesterolIBA 01/2023
1	ChromatinIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Histocompatibility Antigens Class IIBA 10/2022
1	Janus Kinase 1IBA 10/2022
1	rucaparibIBA 06/2022
1	RibonucleotidesIBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	Poly I-CIBA 01/2021
1	LigandsIBA 01/2021
1	Annexin A1IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Thymidine Monophosphate (TMP)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2020
4	Drug Therapy (Chemotherapy) 04/2024 - 01/2020
4	Immunotherapy 01/2023 - 01/2021
1	Castration 04/2024